Opocrin is a globally recognized brand that has been dedicated to the research, isolation, and development of safe and effective biological active ingredients for human use since 1964. Initially founded as a small Research Laboratory by renowned pharmacologist Prof. Pietro Bianchini, Opocrin has evolved into a leading company in the production of heparin derivatives and has become a major player in the API industry.

Opocrin's expertise lies in contract manufacturing, where they collaborate closely with selected partners to develop innovative new products. Their capabilities range from supplying active ingredients for clinical studies to the industrialization of production for commercial purposes. In recent years, Opocrin, in collaboration with their partners, has successfully developed heparin derivatives that are devoid of anticoagulant and antithrombotic activity, opening up new avenues in therapeutic areas.

With a global commercial network operating in over 50 countries, Opocrin has established strategic alliances with top multinational pharmaceutical companies and developed export activities in collaboration with qualified local distributors, ensuring they are always close to their customers. Driven by an ambitious growth strategy, Opocrin has become a solid presence in the global market. Their direct sourcing capabilities for raw materials in the USA, Europe, and China, coupled with their ability to manage the entire product lifecycle from raw materials to commercialization, sets them apart.

Opocrin's headquarters are located in Modena, Italy, and their global presence extends to multiple locations in Italy, Mexico, and China. For more information on their exceptional contract manufacturing services, feel free to contact Opocrin. They have a dedicated team focused on the development and validation of industrial processes, analytical methods, and regulatory support.

Opocrin is committed to maintaining a global presence and making a difference in the market, thanks to their unwavering dedication and strong alliances. (Opocrin's logo and link to their website)